These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 26421710)

  • 1. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
    Farnie G; Sotgia F; Lisanti MP
    Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells.
    Lamb R; Ozsvari B; Bonuccelli G; Smith DL; Pestell RG; Martinez-Outschoorn UE; Clarke RB; Sotgia F; Lisanti MP
    Oncotarget; 2015 Sep; 6(26):21892-905. PubMed ID: 26323205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel.
    Mao J; Song B; Shi Y; Wang B; Fan S; Yu X; Tang J; Li L
    Int J Biochem Cell Biol; 2013 Jun; 45(6):1064-73. PubMed ID: 23500524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling.
    Lamb R; Bonuccelli G; Ozsvári B; Peiris-Pagès M; Fiorillo M; Smith DL; Bevilacqua G; Mazzanti CM; McDonnell LA; Naccarato AG; Chiu M; Wynne L; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Oncotarget; 2015 Oct; 6(31):30453-71. PubMed ID: 26421711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.
    Karimi-Busheri F; Zadorozhny V; Li T; Lin H; Shawler DL; Fakhrai H
    J Stem Cells; 2011; 6(1):9-20. PubMed ID: 22997842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
    Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.
    Ahmadipour F; Noordin MI; Mohan S; Arya A; Paydar M; Looi CY; Keong YS; Siyamak EN; Fani S; Firoozi M; Yong CL; Sukari MA; Kamalidehghan B
    Drug Des Devel Ther; 2015; 9():1193-208. PubMed ID: 25759564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties.
    Wang M; Xiao J; Shen M; Yahong Y; Tian R; Zhu F; Jiang J; Du Z; Hu J; Liu W; Qin R
    Int J Cancer; 2011 Jan; 128(1):72-81. PubMed ID: 20232394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs.
    Ji P; Zhang Y; Wang SJ; Ge HL; Zhao GP; Xu YC; Wang Y
    Oncol Rep; 2016 Jun; 35(6):3293-302. PubMed ID: 27109463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
    Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
    J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldehyde dehydrogenase activity in cancer stem cells from canine mammary carcinoma cell lines.
    Michishita M; Akiyoshi R; Suemizu H; Nakagawa T; Sasaki N; Takemitsu H; Arai T; Takahashi K
    Vet J; 2012 Aug; 193(2):508-13. PubMed ID: 22326935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells.
    Park SY; Kim MJ; Park SA; Kim JS; Min KN; Kim DK; Lim W; Nam JS; Sheen YY
    Oncotarget; 2015 Nov; 6(35):37526-43. PubMed ID: 26462028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
    Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
    Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
    Ózsvári B; Sotgia F; Lisanti MP
    Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.
    Nishikawa S; Konno M; Hamabe A; Hasegawa S; Kano Y; Ohta K; Fukusumi T; Sakai D; Kudo T; Haraguchi N; Satoh T; Takiguchi S; Mori M; Doki Y; Ishii H
    Int J Oncol; 2013 Apr; 42(4):1437-42. PubMed ID: 23440340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signaling.
    Debeb BG; Lacerda L; Xu W; Larson R; Solley T; Atkinson R; Sulman EP; Ueno NT; Krishnamurthy S; Reuben JM; Buchholz TA; Woodward WA
    Stem Cells; 2012 Nov; 30(11):2366-77. PubMed ID: 22961641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MitoTracker Deep Red (MTDR) Is a Metabolic Inhibitor for Targeting Mitochondria and Eradicating Cancer Stem Cells (CSCs), With Anti-Tumor and Anti-Metastatic Activity
    Sargiacomo C; Stonehouse S; Moftakhar Z; Sotgia F; Lisanti MP
    Front Oncol; 2021; 11():678343. PubMed ID: 34395247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
    Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
    BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.
    Emmink BL; Van Houdt WJ; Vries RG; Hoogwater FJ; Govaert KM; Verheem A; Nijkamp MW; Steller EJ; Jimenez CR; Clevers H; Borel Rinkes IH; Kranenburg O
    Gastroenterology; 2011 Jul; 141(1):269-78. PubMed ID: 21459094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.